Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma.
Affiliation
University of Manchester and Cancer Research UK, Paediatric and Familial Cancer Research Group, Royal Manchester Children's Hospital, Manchester, United Kingdom. dong.pang@manchester.ac.ukIssue Date
2008-09-15
Metadata
Show full item recordAbstract
A role for genetic susceptibility in the aetiology of childhood lymphomas was investigated in 454 families of children with histologically confirmed Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) from Northwest England. Cancers in parents were obtained from the UK National Health Service Central Register and in other close relatives by interview with the parents. The cancer incidence among relatives was compared with expected incidence based on cancer registry data for England. There were 197 cancers in relatives (SIR 1.0 95% CI 0.8-1.1). In families of children with HL, there was an excess of HL in the first degree relatives (SIR 5.8 95% CI 1.2-16.9). Excesses of HL diagnosed under population median age (SIR 4.1 95% CI 1.1-10.6) were seen among all relatives and relatives of children who were below the median age at diagnosis (SIR 5.5 95% CI 1.1-16.0). In families of children with NHL, there were non-significant excesses of central nervous system (CNS) tumours in the first degree relatives (SIR 2.9 95% CI 0.8-7.4) and in the second and third degree relatives (SIR 1.5). There were significant excesses of CNS tumours diagnosed under the population median age (SIR 2.8 95% CI 1.1-5.8) in all relatives. Excess CNS tumours were also seen among relatives of children below the median age at diagnosis (SIR 3.2 95% CI 1.1-7.6). In conclusion, genetic susceptibility in some families of children with lymphoma might be operating, but aetiologies in HL and NHL appear to be different. Possible interpretations of our findings, in the context of putative genetic and infectious aetiologies, are discussed.Citation
Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma. 2008, 123 (6):1407-10 Int. J. CancerJournal
International Journal of CancerDOI
10.1002/ijc.23651PubMed ID
18561317Type
ArticleLanguage
enISSN
1097-0215ae974a485f413a2113503eed53cd6c53
10.1002/ijc.23651
Scopus Count
Collections
Related articles
- The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.
- Authors: Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, Haim N, Shachar MB, Epelbaum R, Barchana M, Cohen R, Ben Yehuda D
- Issue date: 2000 May 15
- High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma.
- Authors: Saarinen S, Pukkala E, Vahteristo P, Mäkinen MJ, Franssila K, Aaltonen LA
- Issue date: 2013 Mar 1
- Family history of hematopoietic malignancy and risk of lymphoma.
- Authors: Chang ET, Smedby KE, Hjalgrim H, Porwit-MacDonald A, Roos G, Glimelius B, Adami HO
- Issue date: 2005 Oct 5
- Italian cancer figures, report 2013: Multiple tumours.
- Authors: AIRTUM Working Group
- Issue date: 2013 Jul-Oct
- Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
- Authors: Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort
- Issue date: 2005 Mar 16